Biotek Conversion And AeoniQ Investment Will Unlock Renewable Fiber Demand

Key Takeaways

• Expansion into sustainable fibers and specialty bioproducts increases exposure to higher-margin markets, reduces reliance on commoditized pulp cycles, and supports long-term margin growth.
  
• Vertical integration, cost optimization, and secure sustainable feedstock improve revenue stability and margin resilience, positioning Altri for stronger growth amid evolving market dynamics.
  
• Trade uncertainties, pricing pressures, large investments, and regional operational risks threaten profitability, while diversification efforts carry significant execution and market adoption risks.

Catalysts

Produces and sells cellulosic fibers in Portugal and internationally.

• Altri's strategic investment in AeoniQ and entry into sustainable, high-value cellulosic textile fibers-offering renewable, biodegradable, plastic-free alternatives to polyester and nylon-positions the company to capture expanding demand driven by tighter environmental regulations and global adoption of renewable materials, supporting higher revenues and elevated long-term EBITDA margins.
  
• The full migration of Biotek to dissolving pulp production by end-2026, alongside new acetic acid and furfural capacity, will increase exposure to higher-margin specialty pulp and bioproducts, reducing reliance on commoditized pulp cycles and enabling stronger net margin and earnings growth.
  
• Altri's newly established forestry platform in Northern Spain (via the Greenalia acquisition) strengthens vertical integration and enhances sustainable feedstock security, improving cost control and enabling the company to benefit from growing customer/premium market preference for traceable, certified wood-based products, positively impacting revenue stability and potential margin improvement.
  
• Ongoing and quantifiable cost optimization programs-including improved operational efficiencies, reductions in cash costs, and resource productivity gains from investments in Industrial 4.0-support enhanced EBITDA margins even in periods of market volatility, creating earnings leverage as pricing and demand normalizes.
  
• As global pulp markets stabilize from current tariff disruptions and macro headwinds, Altri is positioned to benefit from the long-term consumption growth of tissue/hygiene and specialty paper in emerging markets, creating a structural upward trend in sales volumes and price realization.

Altri SGPS Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Altri SGPS's revenue will grow by 4.2% annually over the next 3 years.
• Analysts assume that profit margins will increase from 7.9% today to 13.0% in 3 years time.
• Analysts expect earnings to reach €109.7 million (and earnings per share of €0.53) by about August 2028, up from €59.2 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as €170 million.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.8x on those 2028 earnings, down from 17.5x today. This future PE is greater than the current PE for the GB Forestry industry at 10.6x.
• Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 10.99%, as per the Simply Wall St company report.

Altri SGPS Future Earnings Per Share Growth

Risks

• Persistent global trade uncertainties, including newly implemented U.S. tariffs, have directly contributed to pulp demand slowdowns, particularly in Asia, and any prolonged or escalating trade tensions may further depress Altri's international sales, thus negatively impacting revenue growth and long-term earnings visibility.
  
• Weakness in global and regional pulp pricing is evident, with average prices in Europe down 13% in USD and dissolving pulp prices dropping 10% year-on-year, which, coupled with intermittent negative volume trends, places sustained pressure on Altri's net margins and overall profitability.
  
• The planned diversification into textile fibers through AeoniQ, while potentially high margin, introduces execution and scalability risk; given early stage commercial production and uncertain speed of brand adoption in a highly competitive and innovating market, this could delay or diminish the expected earnings uplift for several years.
  
• High capital expenditure requirements in 2025 and 2026-for both the Biotek conversion and AeoniQ investments-are driving up net debt (already at 2.1x EBITDA), making Altri more vulnerable to interest rate risks and to potential cash flow or balance sheet strain if end-market recovery is weaker or slower than anticipated.
  
• Geographic concentration of operations in Portugal and select European markets, combined with elevated working capital driven by seasonal wood stocking, exposes Altri to regional risks (such as drought, forest fires, and regulatory shifts) that could disrupt continuity of operations, heighten costs, and adversely affect long-term revenue and return on capital employed.

Valuation

• The analysts have a consensus price target of €6.17 for Altri SGPS based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €7.1, and the most bearish reporting a price target of just €4.9.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €847.3 million, earnings will come to €109.7 million, and it would be trading on a PE ratio of 15.8x, assuming you use a discount rate of 11.0%.
• Given the current share price of €5.06, the analyst price target of €6.17 is 18.0% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.